ABSTRACT
INTRODUCTION
Systems for expressing foreign proteins on the surface of phage and virus particles have more and more become a matter of interest, as they are a powerful tool for screening ligands in conjunction with their encoding genes. Different techniques have been established for bacterial phage display systems (6, 7, 10, 15, 23) . Moreover, eukaryotes provide the possibility of processing complex and glycosylated proteins. Concepts of eukaryotic, viral expression systems for the display of foreign proteins therefore need to be investigated. Baculovirus expression vectors, particularly those based on Autographa californicanuclear polyhedrosis virus ( Ac NPV), are easily generated and are now widely used for the expression of foreign proteins in cultured insect cells and insect larvae (1, 8) . We previously reported the generation and successful application of a baculovirus vector ( Acomega) that contains a single restriction site ( Sce I) downstream of the polyhedrin promoter and can be used for directly ligating DNA fragments into the viral genome (4) . A similar cloning system has recently been established by Lu and Miller (11) . This technique provides an efficient baculovirus cloning system, which does not necessarily require bacteria for propagation of baculovirus transfer vectors. Based on this method, we wanted to examine the possibility of using the baculovirus expression system for presenting the glycosylated human immunodeficiency virus type 1 (HIV-1) envelope protein gp41 on the virus surface.
For expression on the viral surface, a protein has to either be fused to a viral coat protein (3) or must contain a hydrophobic signal sequence that functions as a membrane anchor. Gp64 is the major envelope glycoprotein of the budding baculovirus virion, which is required for fusion of the viral envelope with the host cell membrane (18) (19) (20) (21) . At its N terminus, gp64 contains a signal peptide, whereas the C terminus bears a 43 amino acid (aa) membrane anchor sequence (22) . Boublik et al. (3) have shown that the HIV-1 envelope protein gp120 is present on the baculovirus surface when being expressed in conjunction with gp64 . In our experiments, we found that fusion proteins containing the entire gp64 were expressed in fairly low concentrations, compared to constructs that only used the C-terminal portion of 43 aa of gp64 for membrane anchorage. In the following approach we chose the glycosylated envelope protein gp41 of HIV-1 (5) as a model for displaying foreign proteins on the viral surface. Baculovirus constructs were generated by fusing gp41 to the entire baculovirus major envelope protein gp64 and, alternatively, to the C-terminal transmembrane domain of gp64. To avoid interference with the HIV-1 gp41 transmembrane region, a truncated version of the gp41gene was used, encoding the ectodomain (aa 492-676) only (5).
MATERIALS AND METHODS
Spodoptera frugiperda cells ( Sƒ 9, CRL 1711; ATCC, Rockville, MD, USA) were grown in IPL-41 medium (Sigma-Aldrich Chemical, Deisenho -fen, Germany) containing yeastolate and a lipid/sterol cocktail with optional 5% or 10% fetal calf serum at 27°C using T-flasks or spinner flasks. Ac -omega (4) and its derivatives were propagated in Sƒ 9 cells. Viruses were isolated and plaque-purified by standard procedures (16) . The amplified virus was banded and purified in 25%-60% wt/vol sucrose gradients, according to the methods described by O'Reilley et al. (13) .
DNA manipulations were carried out essentially as summarized by Sambrook et al. (14) . Restriction enzymes, T4 DNA ligase, calf intestine phosphatase and Taq DNA Polymerase were purchased from Boehringer Mannheim (Vienna, Austria) and used according to the manufacturer's recommendation. All primers were synthesized by Codon (Neusiedl, Austria). Polymerase chain reactions (PCRs) were carried out in a 50-or 100-µ L reaction buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 and 5% dimethyl sulfoxide) using 10 pmol of each primer and 2.5 U of TaqDNA polymerase. Samples were subjected to 25-30 cycles (at 94°, 55°or 60°C and 72°C) on a Model 9600 Thermal Cycler (Perkin-Elmer, Norwalk, CT, USA). The complete gp64 coding region from Ac NPV was amplified by PCR, using the primers gp64 EcoRIback: 5 ′ ccagaattccagttatctggattgctactagtaaatcagtcac3 ′ and gp64EcoRIfor: 5 ′ cctgaattccagataactggttaatattgtctattacggcggtttc3 ′ , treated with Eco RI, cloned into pBluescript ® KS II (Stratagene, La Jolla, CA, USA) and modified by inserting the double-stranded oligonucleotide BbsSceIA/B: 5 ′ gtcctagggataacagggtaat3 ′ / -5 ′ ggacattaccctgttatcccta3 ′ into the naturally occuring Bbs I site at position 139 of the gp64 coding region. The resulting vector was designated pCOPS-II ( Figure 1A ).
The ectodomain of HIV-1 gp41 (aa 492-676) was PCR-amplified from the plasmid ENV-BH10 (kindly provided by Thomas Muster, Institute of Applied Microbiology, University of Agriculture, Food Science and Forestry, Vienna, Austria) with primers gp41BstX1back:
The PCR fragment (gp41) was purified, digested with Bst XI and ligated with Sce I-treated pCOPS-II. Alternatively, the PCR fragment (gp41) was digested with BstXI and NcoI and cloned into the vector pCOPS-II, which after deleting the majority of the gp64 coding region (aa 51-486) with Sce I (compatible with Bst XI) and Nco I would produce N-terminal fusion to the gp64 polypeptide leader and C-terminal fusion to the 43-aa-membrane anchor sequence of gp64. The complete fusion protein was released with Bst XI and inserted into the Sce I linearized Ac -omega (4) (Figure 1 , B and C).
The gp64 promoter was PCR-amplified from Ac NPV wild-type, using the primers gp64leaScefor: 5 ′ atcttgtacggacacataccctgttatccctaggacccgtcttcatttgcgc3 ′and gp64-684Pst1BstXlback: 5'gatctagctatgctgcagccagttatctggctccaaaattgtatcagtgg3 ′ . This PCR fragment by Bst XI, that was ligated into linearized ( Sce I) Ac -omega and generatedAc -cops41. The insert contains the gp64 leader sequence, the gp41 ectodomain and the rest of the gp64 coding sequence. (C) Schematic diagram of the fragment released from pMars41 byBst XI, which was ligated into linearized ( Sce I) Ac -omega and generated Acmars41. The insert contains the gp64 leader sequence, the gp41 ectodomain and the gp64 membrane anchor region. (D) Schematic diagram of the fragment released from pPromars41 by BstXI, which was ligated into linearized ( Sce I) Ac -omega and generated Ac -promars41. The insert contains the gp64 promoter, the gp64 leader sequence, the gp41 ectodomain and the gp64 membrane anchor region.
was treated with Pst I and Sce I, ligated to gp41, then was PCR-amplified with primers 684Pst1BstX1back and gp41 -Nco2031for, treated with Pst I and Nco I and cloned into pCOPS-II. The entire fusion product was released by digesting with Bst XI and inserted into the linearized Ac -omega, producing the recombinant progeny virus Ac -promars41 ( Figure 1D ). The genome structure of all viral constructs was analyzed by restriction digest with BamHI, Pst I, Eco RI and Nco I. Alterations in the banding pattern corresponded to the genetic changes caused by inserting the described fusion genes into the Sce I site of Acomega (data not shown).
Expression of 41MAS64was tested by enzyme-linked immunosorbent assay (ELISA). Cells were infected with 20 plaque-forming units (pfu) per cell, harvested 3 days post infection (p.i.) and lysed in 1% Triton ® X-100 buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 100 µ g/mL phenylmethanesulfonyl (PMSF) and 1 µ g/mL aprotinin (both from Sigma-Aldrich). Samples were serially diluted, starting with a total amount of protein corresponding to 10 6 cells/mL lysis buffer and subjected to ELISA plates precoated with 2 µ g/mL human-anti-gp41 monoclonal antibody (MAb). A kappaspecific human-anti-gp41 MAb was applied as second antibody followed by anti-kappa-alkaline phosphatase conjugate detection (Sigma-Aldrich), using p -nitro-phenylphosphat (pNPP) as a substrate. Optical density was measured at 405 nm. Supernatants of infected Sƒ9 (multiplicity of infection [MOI 20]) cells were harvested 3 days p.i., clarified by centrifugation (1000 × g , 10 min) and purified using a sucrose gradient (25%-60%) (13) . Concentrated virus particles were directly coated onto an ELISA plate starting with a protein concentration (measured by the Bio-Rad protein assay [Hercules, CA, USA]) of 1 µ g/well and diluted. Diluted viral protein samples were incubated with human-anti-gp41 MAb (1.5 µ g/mL) and detected by anti-humanIgG-horse radish peroxidase conjugate using o -phenylene-diamin-dihydrochlorid (OPD) as a substrate. Optical density was measured at 492 nm.
Cell lysates and virus particles were For electron microscopy, Accops41-and Ac -omega-virus particles (MOI 0.3) were harvested 5 days p.i. and purified over a saccharose gradient (25%-60%). Virus samples were adsorbed to carbon-coated copper grid (300 mesh) (Fa. Gröppel, Tulln, Austria) and incubated with a human-antigp41 MAb (1 µ g/mL). Specific labeling was done by anti-human-IgG-gold conjugate. Samples were fixed with glutaraldehyde (2.5%) and treated with 1% uranyl acetate (2 min).
RESULTS AND DISCUSSION
Different baculovirus constructs were generated for the expression of the ectodomain (aa 492-676) of the HIV-1 coat protein gp41 on the viral surface. Boublik et al. (3) described the expression of the HIV-1 envelope protein gp120 on the surface of Ac NPV as fusion protein with the entire baculovirus coat protein gp64. After applying this concept for our model protein (gp41), we additionally constructed a vector that would link the gp41 ectodomain to the C-terminal membrane anchor domain of gp64 (43 aa) only (22) , resulting in the expression of a much smaller recombinant fusion protein. When gp41 was being fused to the entire gp64 ( Figure 1B) , the expression rates were considerably lower than fusion of gp41 to the membrane anchor region of gp64 ( Figure 1C ). Expression of gp41 was detected by ELISA in cell lysates of infected cells (Figure 2) .
The widely used polyhedrin promoter is active very late in the infection cycle (17) , which often results in only partly processed (glycosylated) protein (12) . To circumvent problems that could arise from uncomplete glycosylation, we alternatively used the gp64 promotor (2, 9) . The viral construct Acmars41 contains gp41 fused to the transmembrane sequence of gp64 ( 41MAS64 ) under control of the "very late" polyhedrin promoter. In the construct Ac -promars41, the "early and late" gp64 promoter was positioned upstream of 41MAS64( Figure 1D) . After cloning by direct insertion into the viral genome (4), progeny virus was generated and Sƒ9 cells were infected (16) .
Gp41 expression of Ac -mars41 and Ac -promars41-infected cells was detected by ELISA. Ac -promars41 yielded considerably lower gp41 expression (30%) relative to Ac -mars41 ( Figure  3A) . However, similar amounts of gp41 were detected on the viral surface of Ac -promars41 and Ac -mars41, when purified virus particles were directly coated onto an ELISA plate ( Figure  3B ). These results indicate that virus particles of both viral constructs ( Acmars41 and Ac -promars41) show comparable amounts of gp41 displayed on the viral surface, in spite of considerably lower total expression of 41MAS64 under the gp64 promoter ( Ac -promars41, Figure 3A) .
Western Blot analysis further confirmed expression of 41MAS64in infected cells and its presence on virus particles. Purified virus particles and cell lysates showed specific reactivity with anti-gp41-antibodies (Figure 4) . The protein band at around 32 kDa, detected in all viral and cellular samples corresponds to the size of the predicted fusion protein and represents the fully glycosylated version. The band at 30 kDa, appearing in Ac -mars41 cell lysate (Figure 4, lane 5) and Ac -mars41 virus particles ( Figure 4 , lane 2) represents the non-glycosylated form, concluded from experiments where tunicamycin was used to supress all glycosylation in Ac -mars41-and-Ac -promars41-infected Sƒ9-cells (data not shown). The protein with a molecular weight of about 38 kDa found in both cell lysates (Figure 4 , lanes 5 and 6) is glycosylated, but presumably not completely processed. Only Ac -promars41 (Figure 4 , lane 3) contains one single band corresponding to the predicted size of the correctly processed 41MAS64 .
Using the C-terminal transmembrane domain of the baculovirus coat protein gp64 (22) seems to be sufficient for anchoring foreign proteins to the viral surface. It even results in higher expression levels of the recombinant fusion protein (Figure 2) . We conclude that for baculovirus surface expression, the use of the gp64 promoter (2) is advantageous over the polyhedrin promoter (17) . Transcription under the gp64 promoter occurs earlier in the infection cycle, so that posttranslational modifications can be carried out more efficiently, resulting in correctly processed 41MAS64present in budded virus. Total amount of gp41 measured in cell lysates, was higher when expressed under control of the strong polyhedrin promoter ( Ac -mars41). However, the gp64 promoter seems to be more efficient for expression on the viral surface, in spite of its lower overall activity. ELISA results demonstrate lower expression of 41MAS64in cell lysates of Ac -promars41, but similar expression levels on the viral surface of both viruses (Figure 3, A virus particles indicated the prefered incorporation of the processed protein fraction (around 32 kDa) on the viral surface of Ac -promars41.
The expression of gp41 on the surface of Ac -cops41 was analyzed by electron microscopy ( Figure 5 ). Specific staining of gp41 using a monoclonal anti-gp41 MAb and anti-human-IgGgold conjugate could be detected. No specific staining was detected with Acomega (data not shown).
Expression of the HIV-1 envelope protein gp41 (5) on the surface of recombinant baculoviruses demonstrates promising first steps towards the establishment of an eukaryotic surface display system, where complex, glycosylated proteins can be presented on the surface of viral particles. Boublik et al. (3) were the first to demonstrate that fusing a foreign protein to gp64 leads to expression on the surface of baculovirus particles. In our approach, we tested the feasability of the C-terminal membrane anchor region of the viral coat protein gp64 for anchoring foreign proteins to the viral surface ( 41MAS -64 ). We emphasize the importance of the used promoter concerning posttranslational modifications and the yield of the target protein. Further promoter studies together with detailed characterization of the expressed fusion protein (N-terminal peptide sequencing, glycosylation studies) have to be done to determine the optimal time of transcription and rate of expression.
